Farmmi Inc

Aktienanalyse zu Farmmi Inc (FAMI)

$0.093

+0.003 (+2.88%)Zum Schluss

Loading chart…
Hoch
0.098
Eröffnung
0.096
Volumengewichteter Durchschnittskurs
0.09
Volumen
2.14M
Marktkap.
4.70M
Tief
0.092
Umsatz
201.19K
EV/EBITDA, TTM
0.00

Farmmi Inc is a holding company principally engaged in the processing and sales of a variety of mushrooms, edible fungi and other agricultural products. The Company’s main products include edible fungi (edible mushroom), shiitake, Mu Er, bamboo fungi, agrocybe aegerila, pleurotus eryngii, grifola frondosa and other agricultural products such as crab, orange, rice and others. The Company distributes products under brand Lishui Shangeng, Farmmi Liangpin, Forasen, and others. The Company distributes products in the domestic and overseas markets, including the U.S., Japan, Canada, and other countries or regions.

farmmi.com

KI-Analyse of Farmmi Inc (FAMI)

Verkaufen

Farmmi Inc is not a good buy right now due to its significant financial struggles and negative market sentiment. The stock has a current price of $0.09, which is near its 52-week low of $0.09, and it has experienced a staggering year-to-date change of -92.79%. Additionally, the company's forward P/E ratio is 0, indicating no expected earnings growth, and it recently completed a public offering at a 79% discount, which has raised concerns about its financial health. The main risk is the company's substantial net loss of $53.4 million for the fiscal year ending September 30, 2025, alongside a revenue decline of over 56%.

Bewertungskennzahlen

Das aktuelle erwartete KGV von Farmmi Inc (FAMI) beträgt 0.00, verglichen mit dem 5-Jahres-Durchschnitt von 0.00.

Erwartetes KGV

Stark unterbewertet
5J-Durchschnitt P/E
0.00
Aktuelles P/E
0.00
Überbewertet
0.00
Unterbewertet
0.00

Erwartetes EV/EBITDA

Stark unterbewertet
5J-Durchschnitt EV/EBITDA
0.00
Aktuelles EV/EBITDA
0.00
Überbewertet
0.00
Unterbewertet
0.00

Erwartetes KUV

Stark unterbewertet
5J-Durchschnitt P/S
0.00
Aktuelles P/S
0.00
Überbewertet
0.00
Unterbewertet
0.00

Alphio-AI-Kursszenarien für FAMI

Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

B

Bullisch

Bullisch · 25%FAMI

$1.91

Szenariopreis

B

Basis

Basis · 50%FAMI

$1.68

Szenariopreis

B

Bärisch

Bärisch · 25%FAMI

$1.45

Szenariopreis

Event-Zeitleiste

2026-08-04 (ET)

17:30:00

Farmmi Signs Acquisition Agreement to Acquire 100% Equity of Four Seasons Holding Group

2026-06-29 (ET)

08:00:00

Farmmi Prices Public Offering Expected to Raise $3M

2026-03-11 (ET)

07:10:00

Farmmi Subsidiary Receives Hazardous Materials Permit in California

2026-01-26 (ET)

07:10:00

Farmmi Establishes Wholly-Owned Subsidiary Bluesage Marketing for Digital Marketing

2026-01-14 (ET)

07:10:00

Farmmi Subsidiary Achieves FDA Food Facility Registration

News

FAMI FAQ – beantwortet von Alphio AI

Farmmi Inc is a holding company principally engaged in the processing and sales of a variety of mushrooms, edible fungi and other agricultural products. The Company’s main products include edible fungi (edible mushroom), shiitake, Mu Er, bamboo fungi, agrocybe aegerila, pleurotus eryngii, grifola frondosa and other agricultural products such as crab, orange, rice and others. The Company distributes products under brand Lishui Shangeng, Farmmi Liangpin, Forasen, and others. The Company distributes products in the domestic and overseas markets, including the U.S., Japan, Canada, and other countries or regions. It operates in the Consumer Non-Cyclicals sector (CANNED FRUITS, VEGETABLES, PRESERVES, JAMS, AND JE industry).

Farmmi Inc is not a good buy right now due to its significant financial struggles and negative market sentiment. The stock has a current price of $0.09, which is near its 52-week low of $0.09, and it has experienced a staggering year-to-date change of -92.79%. Additionally, the company's forward P/E ratio is 0, indicating no expected earnings growth, and it recently completed a public offering at a 79% discount, which has raised concerns about its financial health. The main risk is the company's substantial net loss of $53.4 million for the fiscal year ending September 30, 2025, alongside a revenue decline of over 56%.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Ähnliche Artikel

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln